IRIS
SACCO, RODOLFO, COSMA, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.939
EU - Europa 1.759
AS - Asia 1.484
SA - Sud America 227
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 2
Totale 5.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.905
CN - Cina 530
IE - Irlanda 514
SG - Singapore 458
UA - Ucraina 315
SE - Svezia 310
BR - Brasile 186
RU - Federazione Russa 168
VN - Vietnam 150
HK - Hong Kong 118
IT - Italia 113
IN - India 101
DE - Germania 99
FI - Finlandia 82
GB - Regno Unito 80
TR - Turchia 63
FR - Francia 32
CA - Canada 18
BE - Belgio 17
AR - Argentina 16
EU - Europa 11
MX - Messico 11
TW - Taiwan 10
CO - Colombia 9
BD - Bangladesh 6
IQ - Iraq 6
JP - Giappone 6
PL - Polonia 6
RO - Romania 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
AT - Austria 4
EC - Ecuador 4
PH - Filippine 4
VE - Venezuela 4
CL - Cile 3
DO - Repubblica Dominicana 3
ES - Italia 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
BN - Brunei Darussalam 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
TN - Tunisia 2
UZ - Uzbekistan 2
AU - Australia 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
NL - Olanda 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.439
Salva come PNG Salva come JPEG
Città #
Dublin 514
Chandler 323
Jacksonville 220
Singapore 215
Nyköping 195
Dearborn 148
Beijing 140
Hong Kong 118
Nanjing 114
Ashburn 98
Wilmington 93
Dong Ket 75
Ann Arbor 65
Santa Clara 64
New York 54
San Mateo 54
Princeton 53
Woodbridge 50
Moscow 46
Nanchang 38
Helsinki 35
Boardman 31
Munich 31
Ho Chi Minh City 27
Philadelphia 27
Dallas 26
Cedar Knolls 23
Shenyang 23
Los Angeles 20
Tianjin 20
Changsha 19
Hanoi 19
Stevenage 19
São Paulo 18
Brussels 17
Jiaxing 17
Hebei 16
Des Moines 13
Kunming 13
Hilden 12
Guangzhou 10
Banqiao 9
Belo Horizonte 9
Rio de Janeiro 9
Foggia 8
Hangzhou 8
Toronto 8
Brasília 7
Milan 7
Nuremberg 7
Rome 7
Shanghai 7
Changchun 6
Chicago 6
Council Bluffs 6
Kocaeli 6
London 6
Ningbo 6
Auburn Hills 5
Bari 5
Borås 5
Chennai 5
Curitiba 5
Da Nang 5
Las Vegas 5
Leawood 5
The Dalles 5
Tokyo 5
Warsaw 5
Augusta 4
Brooklyn 4
Cluj 4
Fairfield 4
Houston 4
Jinan 4
Ninh Bình 4
Porto Alegre 4
Pune 4
San Francisco 4
Seattle 4
Taizhou 4
Turku 4
Zhengzhou 4
Asunción 3
Buffalo 3
Campo Grande 3
Frankfurt am Main 3
Johannesburg 3
Lanzhou 3
Orange 3
Quezon City 3
San Jose 3
Shenzhen 3
Sumaré 3
Trani 3
Vancouver 3
Vienna 3
Washington 3
Ahmedabad 2
Baghdad 2
Totale 3.395
Salva come PNG Salva come JPEG
Nome #
Chemioembolizzazione con particelle embolizzanti a rilascio farmacologico (DEB-TACE) vs tecnica convenzionale (TACE): risposta tumorale e sopravvivenza in pazienti con HCC 244
228 CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (C-TACE) VERSUS DOXORUBICIN ELUTING BEAD (DEB)-TACE FOR HEPATOCELLULAR CARCINOMA: ASSESSMENT OF CLINICAL IMPACT-SHORT AND LONG-TERM PROSPECTIVE STUDY 206
526 Liver stiffness measured by transient elastography. The influence of biochemical activity 141
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cells 140
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutants 139
504 HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance 136
[GLUTATHIONE IN THE TREATMENT OF CHRONIC FATTY LIVER DISEASES] 134
Cost effective prediction of sustained response to IFN Alfa-2B or PEG-IFN Alfa 2B plus Ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline 123
Transient elastography improves the management of CHB patients 118
HBeAg defective mutants in active/inactive anti-HBe positive HBsAg carriers: possible role of pre-core initiation mutants 114
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. 114
Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells 114
Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? 110
Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease 110
Survival after transarterial chemoembolization in early-stage HCC patients excluded from liver transplantation: a prospective cohort study 110
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. 106
Liver stiffness measured by transient elastography: The influence of biochemical activity 104
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. 104
EARLY AND COST EFFECTIVE PREDICTION OF TREATMENT OUTCOME WITH IFNA2B OR PEG-IFNA2B PLUS RIBAVIRIN COMPUTING INFECTED CELLS DYNAMICS BY ALT AND HCV-RNA DECLINE DURING THE FIRST MONTH 104
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy. 103
Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux disease 100
Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study 99
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. 99
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. 98
Complete response for advanced liver cancer during sorafenib therapy: case report. 98
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study 97
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. 96
MONITORING LIVER STIFFNESS: A NEW TOOL TO MEASURE LIVER FIBROSIS DURING THERAPY 96
Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy 96
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. 95
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy. 94
Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective color study 94
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. 93
Conventional vs Doxorubicin Eluting Bead Transcatheter Chemoembolization for Hepatocellular Carcinoma. 90
A new model of HBV infection dynamics shows a multiphasic decay of viral load and a short half-life of circulating virus in anti-HBe positive patients treated with lamivudine 89
Endotics system versus colonscopy for the detection of polyps a randomised trial 88
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review 87
Adherence to AASLD guidelines in the real world of HCC in Italy preliminary results of a prospective study 85
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. 82
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C. 77
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 77
Effectiveness of hemostatic powders in lower gastrointestinal bleeding: a systematic review and meta-analysis 75
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. 74
Valutazione dell’impatto sulla funzionalità epatica della chemioembolizzazione in pazienti con epatocarcinoma tecnica convenzionale Versus particelle embolizzanti. 73
Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis: A Systematic Review and Meta-Analysis 72
Endotics system vs colonoscopy for the detection of polyps 68
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis 67
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma 66
Sustained response to Interferon-ribavirin combination therapy in chronich hepatitis C predicted by a model of viral dynamics using both HCV-RNA and alanine amino transferase. 64
Towards a tailored systemic therapy for liver cancer 63
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 54
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials 48
Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis 46
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies 43
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review 42
Cholangiocarcinoma in the Era of Immunotherapy 42
Bright Luminal Sign on High b-Value Diffusion-Weighted Magnetic Resonance Enterography Imaging as a New Biomarker to Predict Fibrotic Strictures in Crohn’s Disease Patients: A Retrospective Preliminary Study 42
Target therapies plus somatostatin analogues in NETs: a network meta-analysis 39
Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947" 33
An Unusual Case of Herpes Zoster of the Hand Following a Physical Trauma: Case Report and Literature Review 9
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 7
Totale 5.531
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021322 0 0 0 0 0 17 52 9 55 100 7 82
2021/2022365 53 4 9 8 54 25 16 21 47 37 7 84
2022/20231.416 116 79 82 112 71 124 6 133 620 10 40 23
2023/2024183 42 14 4 4 16 62 2 5 2 14 1 17
2024/2025894 36 7 12 28 61 103 89 50 286 42 80 100
2025/2026797 110 99 194 210 132 52 0 0 0 0 0 0
Totale 5.531